2,3-Dihydro-LSD

2,3-Dihydro-LSD
Clinical data
Other names2,3-DH-LSD; DH-LSD; 2,3-Dihydrolysergic acid diethylamide; N,N-Diethyl-6-methyl-9,10-didehydro-2,3-dihydroergoline-8β-carboxamide
Routes of
administration		Oral
Drug classSerotonergic psychedelic; Hallucinogen
ATC code
  • None
Identifiers
  • (6aR,9R)-N,N-diethyl-7-methyl-5,5a,6,6a,8,9-hexahydro-4H-indolo[4,3-fg]quinoline-9-carboxamide
PubChem CID
ChemSpider
Chemical and physical data
FormulaC20H27N3O
Molar mass325.456 g·mol−1
3D model (JSmol)
  • CCN(CC)C(=O)[C@H]1CN([C@@H]2CC3CNC4=CC=CC(=C34)C2=C1)C
  • InChI=1S/C20H27N3O/c1-4-23(5-2)20(24)14-9-16-15-7-6-8-17-19(15)13(11-21-17)10-18(16)22(3)12-14/h6-9,13-14,18,21H,4-5,10-12H2,1-3H3/t13?,14-,18-/m1/s1
  • Key:JBWYWLQLZXGQJF-JDPNFYKBSA-N

2,3-Dihydro-LSD, or 2,3-DH-LSD, also known as 2,3-dihydrolysergic acid diethylamide, is a psychedelic drug of the lysergamide family related to lysergic acid diethylamide (LSD). It is the analogue of LSD in which the 2,3- double bond in the indole ring within the ergoline ring system has been hydrogenated.

This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.